Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
48
Our research program provides an in-terdisciplinary blend of synthetic and medicinal chemistry that includes the
total synthesis of natural products, the discov-ery of new reactions, as well as the evaluation for their cellular mechanism and medicinal properties.
Natural product synthesis: Natural products are still the primary source for medicines, and marine sponge metabolites represent a highly diverse and complex class of natural products with remarkable biological activities. Members of our lab will develop new heterocyclic methodologies to efficiently access these natural products.1,4,5 Cellular studies in our lab will subsequently be performed to identify the biological target responsible for the exciting biological properties these compounds elicit.2,6,7
Medicinal chemistry: Our medicinal chemistry program is aimed at the development of more drug-like scaffolds containing a skeletal diversity inspired by natural products. One of our biological targets includes the human proteasome.
Cancer research: Inhibition of the proteasome is clinically validated for the treatment of multiple myeloma, however nearly all patients relapse after some time. Our natural product-inspired scaffolds elicit a unique mechanism of inhibition of this large protease that overcomes resistance to current cancer therapies.2, 6
Alzheimer’s and related research: In Alzheimer’s disease and related dementias, amyloid oligomers inhibit the activity of the proteasome, resulting in the accumulation, oligomerization and aggregation of disordered proteins such as Aβ, tau and α-synuclein.3 Our research team is exploring the use of small heterocyclic scaffolds to activate a specific sub-complex of the proteasome, the 20S proteasome, to treat these neurodegenerative diseases.7
Selected PublicationS
AssociAte Professor (b. 1968)
B.S., 1992, Jacksonville Univ.;
Ph.D., 1997, Univ. of Virginia;
Postdoctoral Research, 1998-2000, Colorado State Univ.
517-353-0497
Synthetic and Medicinal Chemistry
Jetze J. Tepe
1. Regulation of Autophagic Flux by the 20S proteasome. Cell, Njomen, Evert and Tepe, Jetze, Cell Chemical Biology 2019, in print, CCBIO3321.
2. Proteasome activation as a new thera-peutic approach to target proteotoxic disorders, Njomen, Evert and Tepe, Jetze J., J. Med. Chem. 2019, in print, DOI:10.1021/ acs.jmedchem.9b00101.
3. Diastereoselective one-pot synthesis of oxazolines using sulfur ylides and acyl imines, Mehedi, Md Shafaat Al and Tepe, Jetze J., J. Organic Chemistry 2019, 84, 7219-7226.
4. Pipecolic esters as new templates for proteasome inhibition, Giletto, Matthew B; Osmulski, Pawel A.; Jones, Corey L.; Gaczynska Marie E. and Tepe, Jetze J., Org. & Biomol. Chem. 2019, 17, 2734-2746.
5. Substrate Controlled Regioselective Bromination of 2-Aycl Pyrroles Using Tetrabutyl Ammonium Tribromide (TBABr3), Gao, Shuang, Bethel, Travis K. Kakeshpour T.; Hubbell, Grace E., Jackson, James, E. and Tepe, Jetze J., J. Org. Chem. 2018, 83, 9250-9255. PMID: 29969032
6. Small Molecule Modulation of Proteasome Assembly, Njomen, Evert; Osmulski, Pawel A.; Jones, Corey L; Lansdell, Theresa A. Gaczynska, Maria E. and Tepe, Jetze J., Biochem. 2018, 57, 4214-4224. PMID: 29897236
7. Small molecule enhancement of 20S proteasome activity targets intrinsi-cally disordered proteins, Jones, Corey L.; Njomen, Evert; Sjogren B.; Dexheimer, Thomas S. and Tepe, Jetze J. ACS Chem.Biol. 2017, 15;12(9), 2240-2247. PMID: 28719185.
NH
O
O OH
Salinosporamide A
Cl
O
H
NHN O
NMe
Me
NH
O
5-(1H-indol-3-yl)-imidazolones
NH
NH
O
N
HNOH2N
Debromohymenialdisine
NNH
O
Br
Br
NH
HN
O
O
Agesamide A/B
NN
HNNH
O
NH
HNH2
H
NN
O
Br
Br
ClN
NH
NH2HO
Palau'amineX = NH2, DibromophakellinX = OH, Dibromophakellstatin
HN N
X
N
O
NH
Cylindradine A
HN NH
NH
Br
Br
NH O
Br
BrHN N
NH
HNHO O
Nagelamide MSO3
NH
CO2H
NH
NR
NHR
Br
Br
Trachycladindoles
NH OH
H R2
R1
Benzastatin F: R1 = CH2OCH3, R2
= Me
Benzastatin F: R1
= Me, R2
= Me
Benzastatin G: R1 = Me, R2 = H
O
H2N
N
Br
Br
NH
O NHN
NH
N NH2
N
NCO2EtH3CO
HN
Ph
TCH-165
N N
Br
HN N
O
H2N
Our synthetic palau’amine mimic bound in the catalytic site of the proteasome
- Angewandte Chemie Int. Ed. 2015, 54, 2830-2833
Our synthetic palau'amine mimic bound in the catalytic site of the proteosome
–Angewandte Chemie Int. Ed. 2015, 54, 2830-2833.
N
NR1
R4 R3
CO2HR2
NR1
R4 R3
CO2HR2
R3 R4
NHN O
H2N
N
HN O
R1
R4R 3
O
NR1
R2
R3
NH
Br R2
NN
NR1R2
R3 R3
CO2H
NH
OR5
R3O CO2HR2
R4
O
NR1
R2
R3
Development of new reactions for the synthesis of drug-like scaffolds:
TCH-165 opens the gate of the 20S proteasome and enhances α-synuclein degradation. A. AFM images of 20S α-ring showing TCH-165 opening the gate of the 20S, rendering an activated 20S proteasome. B. Coomassie stain of TCH-165 enhanced degradation of α-syn (and oligomers) by the 20S in vitro.